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Abstract 
Background: Equine coronavirus (ECoV) is considered to be a diarrheic pathogen in foals. In central Kentucky in the 
United States, it has been shown that approximately 30 % of thoroughbred foals are infected with ECoV and thus it is 
considered widely prevalent. In contrast, the epidemiology of ECoV and its relationship to diarrhea in foals are poorly 
understood in Japan. We investigated ECoV in rectal swabs collected from thoroughbred foals in Japan.
Results: We collected 337 rectal swabs from 307 diarrheic foals in the Hidaka district of Hokkaido, the largest thor-
oughbred horse breeding region in Japan, between 2012 and 2014. In addition, 120 rectal swabs were collected from 
120 healthy foals in 2012. These samples were tested by reverse transcription loop-mediated isothermal amplifica-
tion and a real-time reverse transcription-polymerase chain reaction. All samples collected from diarrheic foals were 
negative, and only three samples (2.5 %) collected from healthy foals were positive for ECoV. Compared with central 
Kentucky, ECoV is not prevalent among thoroughbred foals in the Hidaka district of Hokkaido.
Conclusion: ECoV is not prevalent and was not related to diarrhea in thoroughbred foals in the Hidaka district of 
Hokkaido between 2012 and 2014.
Keywords: Equine coronavirus, Foal, Japan, Reverse transcription loop-mediated isothermal amplification, Real-time 
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Findings
Certain pathogens are common causes of diarrhea in 
foals, equine rotavirus being the most common [1]. 
Equine coronavirus (ECoV) is also a diarrheic pathogen 
in foals [2]. Recently, several ECoV outbreaks in adult 
horses occurred in the United States [3] and Japan [4–6]. 
Fever, anorexia, lethargy, leukopenia and digestive disor-
ders were observed, and these clinical signs were repro-
duced in an experimental challenge study [7]. Equine 
coronavirus was also detected in fecal samples of diar-
rheic foals in the United States [8, 9], but there have been 
no reports of an ECoV outbreak in foals.
Slovis et  al. [10] reported that approximately 30  % of 
healthy and diarrheic thoroughbred foals in central Ken-
tucky in the United States were infected with ECoV, using 
a real-time reverse transcription-polymerase chain reac-
tion (RT-PCR) assay. These results indicate that ECoV 
is prevalent among thoroughbred foals in central Ken-
tucky. In Japan, ECoV outbreaks had previously occurred 
only in the draft racehorse population. Draft racehorses 
include French Percheron, Breton and Belgian horses, 
with body weights around 1000  kg. Outbreaks of ECoV 
had not been reported in the Japanese thoroughbred 
horse population, and its epidemiology is poorly under-
stood. It is also unclear whether ECoV is related to diar-
rhea in Japanese foals. Therefore, we investigated ECoV 
using molecular diagnostic methods on rectal swabs 
collected from thoroughbred foals in the Hidaka district 
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of Hokkaido, which is the largest thoroughbred horse 
breeding region in Japan.
Between 2012 and 2014, we collected 337 rectal swabs 
from 307 diarrheic foals aged 2  days to 5  months in 
the Hidaka district of Hokkaido by using BD BBL Cul-
tureSwab EZ (Becton, Dickinson and Company, Fuku-
shima, Japan). Rectal swabs of twenty-two and four 
diarrheic foals were collected twice and three times, 
respectively. Multiple samples were collected with 
3–106  days intervals (average 28.5  days). We collected 
121 samples from 63 farms in 2012, 121 samples from 
63 farms in 2013 and 95 samples from 44 farms in 2014. 
Rectal swabs from diarrheic foals were stored at −20 °C 
in the veterinary clinic until transport. They were trans-
ported to the diagnostic laboratory at around −18  °C, 
and after arrival they were kept at −80 °C until use. Addi-
tionally, 120 rectal swabs were collected from 120 healthy 
foals on 30 farms in the same region in 2012 by using BD 
BBL CultureSwab Plus (Becton, Dickinson and Com-
pany). Healthy foals were between 1 and 80 days of age. 
Rectal swabs from healthy foals were stored and trans-
ported at 4  °C for several days. After arrival, they were 
kept at −80  °C until use. These samples were immersed 
in maintenance medium [11] or phosphate buffered 
saline. Viral RNA was extracted from samples with 
MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche 
Diagnostics, Mannheim, Germany).
Reverse transcription loop-mediated isothermal ampli-
fication (RT-LAMP) and real-time RT-PCR assays were 
selected because these molecular methods have high 
sensitivity for ECoV [12]. The RT-LAMP reaction was 
performed using a primer set described previously [12] 
and a Loopamp RNA Amplification Kit (Eiken Chemical, 
Tokyo, Japan) according to the manufacturer’s instruc-
tions. Calcein, a fluorescent detection reagent (Eiken 
Chemical, Tokyo, Japan), was added to the reaction mix-
ture for visual detection. The mixtures were incubated at 
60  °C for 40 min and then heated at 95  °C for 2 min to 
terminate the reaction.
Real-time RT-PCR assay was conducted using a primer 
set described previously (ECoV-380f, ECoV-522r and 
ECoV-436p) [3] and TaqMan Fast Virus 1-Step Master 
Mix (Applied Biosystems, Foster City, CA, USA) accord-
ing to the manufacturer’s instructions. Thermal cycling 
was performed as [7]: 50 °C for 5 min and 95 °C for 20 s, 
followed by 40 cycles at 94 °C for 3 s and 60 °C for 30 s.
For sequence and phylogenetic analysis of the nucle-
ocapsid (N) gene, RT-PCR was performed using the 
primer set ECoV-Nf (5′-tcaggcatggacaccgcattgtt-3′) and 
ECoV-Nr (5′-ccaggtgccgacataaggttcat-3′) [5] using Pri-
meScript II High Fidelity One Step RT-PCR Kit (Takara 
Bio, Otsu, Japan). RT-PCR products were directly 
sequenced commercially by Fasmac (Atsugi, Japan). 
Sequence analysis was performed using the BLAST and 
CLUSTALW programs, and Vector NTI Advance 11 
software (Invitrogen, Carlsbad, CA, USA). Phylogenetic 
analysis of nucleotide sequences was conducted with 
MEGA software Version 5.2 [13]. A phylogenetic tree 
was constructed based on nucleotide sequences using the 
neighbor-joining method. Statistical analysis of the tree 
was performed with the bootstrap test (1000 replicates) 
for multiple alignments. The nucleotide sequences of the 
N gene in Hidaka-No.61/2012 and Hidaka-No.119/2012 
have been deposited in GenBank/EMBL/DDBJ under 
the accession numbers LC054263 and LC054264, respec-
tively. The N gene of NC99 (AF251144), Obihiro2004 
(AB671298), Tokachi09 (AB555559) and Obihiro12-1 
(AB775893) were used to compare with that of Hidaka-
No.61/2012 and Hidaka-No.119/2012.
All 337 samples collected from diarrheic foals were 
negative for ECoV on RT-LAMP and real-time RT-PCR 
assays. Three samples collected from healthy foals aged 
30–39 days at two farms were positive for ECoV on RT-
LAMP and real-time RT-PCR assays. N gene amplifica-
tion was attempted in the three positive samples and was 
successful in two of them (Hidaka-No.61/2012 collected 
at A farm in April 2012 and Hidaka-No.119/2012 col-
lected at B farm in April 2012).
Sequence analysis was performed for the N gene (1341 
nucleotides and 446 amino acids) of Hidaka-No.61/2012 
and Hidaka-No.119/2012. The nucleotide and amino acid 
sequence identities between the two samples analyzed in 
this study and in four other ECoVs (NC99 [9, 14], Obi-
hiro2004 [4], Tokachi09 [5] and Obihiro12-1 [6] strains) 
are shown in Table  1. The sequence identity of Hidaka-
No.61/2012 with the other four ECoVs was 98.2–99.9 % 
at the nucleotides and 97.3–100  % at the amino acids. 
Sequence identity of Hidaka-No.119/2012 with the other 
four ECoVs was 97.8–99.2 % at the nucleotides and 96.6–
98.9 % at the amino acids.
Phylogenetic analysis was performed for the nucleo-
tide sequences of the N gene (Fig.  1). Phylogenetic 
analysis showed that Hidaka-No.61/2012 and Hidaka-
No.119/2012 are closely related to the Obihiro12-1 and 
Tokachi09 strains, respectively.
In this study, all diarrheic samples were negative for 
ECoV. This indicates that ECoV is not a causative agent 
of diarrhea in thoroughbred foals in Hidaka district of 
Hokkaido. Using 120 rectal swabs collected from healthy 
foals, only three samples (2.5 %) were positive for ECoV. 
Rectal swabs from healthy foals preserved at worse con-
dition than that of diarrheic foals as described above. 
However, ECoV was only detected in rectal swabs from 
healthy foals, and therefore it is unclear whether storage 
condition influenced the result in this study. Compared 
with central Kentucky, ECoV is not prevalent among 
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thoroughbred foals in Hidaka district of Hokkaido, but 
some outbreaks have occurred in draft racehorses. One 
reason for the lack of ECoV positive samples in thor-
oughbred foals may be that they do not usually have 
contact with draft horses. These results suggest that the 
prevalence of ECoV varies greatly depending on region. 
To further show this, it is necessary to investigate ECoV 
in other countries as well.
In sequence and phylogenetic analyses of the N gene, 
there is little difference between Hidaka-No.61/2012 
and Obihiro12-1. Obihiro12-1 was isolated in the ECoV 
outbreak in March 2012 [6], and therefore the Hidaka-
No.61/2012 collected in April 2012 may have come 
from a virus circulating during the outbreak. In con-
trast, Hidaka-No.119/2012 did not come from an Obi-
hiro12-1-like virus based on sequence and phylogenetic 
analyses. Ultimately, Hidaka-No.61/2012- and Hidaka-
No.119/2012-like viruses did not establish themselves 
in thoroughbred foals in Hidaka district of Hokkaido, 
because ECoV was not detected in any diarrheic samples 
in 2013 or 2014.
In conclusion, this study shows that ECoV is not prev-
alent and was not related to diarrhea in thoroughbred 
foals in the Hidaka district of Hokkaido between 2012 
and 2014.
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Table 1 Sequence identities of the nucleocapsid gene between ECoVs identified in this study and other ECoVs
Strains Hidaka-No.61/2012 Hidaka-No.119/2012
Nucleotide (nt) Amino acid (aa) Nucleotide Amino acid
NC99 98.2 % (1317/1341nt) 97.3 % (434/446aa) 97.8 % (1311/1341nt) 96.6 % (431/446aa)
Obihiro2004 98.5 % (1321/1341nt) 97.5 % (435/446aa) 98.2 % (1317/1341nt) 97.1 % (433/446aa)
Tokachi09 99.3 % (1331/1341nt) 98.9 % (441/446aa) 99.1 % (1329/1341nt) 98.7 % (440/446aa)












Fig. 1 Phylogenetic analysis of the nucleotide sequences of the nucleocapsid gene of equine coronavirus. Closed circles indicate two equine 
coronaviruses analyzed in this study (Hidaka-No.61/2012 and Hidaka-No.119/2012). The percentage bootstrap support is indicated by the value at 
each node; values <70 % are omitted. Scale bars indicate nucleotide substitutions per site. BCoV (Bovine coronavirus) Kakegawa strain is used as an 
out-group
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